Shionogi & Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Shionogi & Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Shionogi & Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Shionogi & Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Shionogi & Co Ltd (Shionogi) is a research-driven pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceuticals. The company focuses on prescription drugs, over-the-counter (OTC) drugs, and diagnostics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D activities are focused on developing drugs in therapeutic areas including infectious diseases, psychoneurological diseases, oncology and sarcopenia. Under infectious diseases, the company focuses on developing vaccines and diagnostic kits for influenza, SARS-CoV-2; vaccines for HIV, malaria, COVID-19 and tuberculosis; in psychiatric disorders and neurological diseases the company focuses on developing drugs for attention-deficit hyperactivity disorder; Alzheimer's disease, pain, and depression. In FY2025, the company spent JPY108,612 million on its R&D activities, which as a percentage of revenue stood at 24.8%, and grew 5.8% YoY. The company works in partnership with Sage Therapeutics, Takeda, Roche, Nagasaki University, GSK, Vast Therapeutics, Nissan Chemical Corp, Sanofi and others to discover new products and expand its existing products for new indications.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer